Researcher profile
Pierre michel Llorca
Affiliations
Organizations
Centre Hospitalier Universitaire de Clermont-Ferrandauthorship · FRCentre National de la Recherche Scientifiqueauthorship · FRFondation FondaMentalauthorship · FRHôpital Saint-Jacquesauthorship · FRHospital Virgen de la Luzauthorship · ESInsermauthorship · FRInstitut Pascalauthorship · FRUniversité Clermont Auvergneauthorship · FRUniversity of Clermont Auvergneauthorship · FR
Public evidence
7 connected articles
The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies.2024 · Europe PMCCannabis use and cognitive biases in people with first-episode psychosis and their siblings.2024 · Europe PMCThe Role of Social Deprivation and Cannabis Use in Explaining Variation in the Incidence of Psychotic Disorders: Findings From the EU-GEI Study.2024 · Europe PMCCannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study.2023 · Europe PMCRepetitive Transcranial Magnetic Stimulation (rTMS) as a Promising Treatment for Craving in Stimulant Drugs and Behavioral Addiction: A Meta-Analysis2022 · PubMed Central Open AccessDaily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study.2021 · PubMed Central Open AccessThe continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study.2021 · PubMed Central Open Access
Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.